Sigyn Therapeutics (SIGY) Raw Materials (2016 - 2020)
Sigyn Therapeutics (SIGY) posted Raw Materials of $62977.0 for Q3 2020, down 83.88% sequentially from $390725.0 in Q2 2020, and little changed YoY from $62977.0 in Q4 2019.
Sigyn Therapeutics (SIGY) Raw Materials (2016 - 2020) Analysis & Trends
Sigyn Therapeutics has reported Raw Materials for 5 years, with the latest figure at $62977.0 in Q3 2020.
- Quarterly Raw Materials changed 0.0% year-over-year to $62977.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $62977.0 (changed 0.0% YoY) and the FY2019 annual result came in at $390988.0, down 25.73% from the prior year.
- Raw Materials fell to $62977.0 in Q3 2020 per SIGY's latest filing, from $390725.0 in the prior quarter.
- Over five years, Raw Materials peaked at $529018.0 in Q4 2017 and troughed at $62977.0 in Q3 2019.
- A 5-year average of $337368.6 and a median of $390856.5 in 2019 frame the typical range for Raw Materials.
- The widest YoY moves for Raw Materials: up 286.32% in 2019, down 53.05% in 2019.
- Over 5 years, Raw Materials stood at $478096.0 in 2016, then increased by 10.65% to $529018.0 in 2017, then retreated by 0.48% to $526473.0 in 2018, then fell by 25.73% to $390988.0 in 2019, then tumbled by 83.89% to $62977.0 in 2020.
- According to Business Quant data, Raw Materials over the past three periods registered $62977.0, $390725.0, and $390725.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 62,977.00 |
| Jun 30, 2020 | 390,725.00 |
| Mar 31, 2020 | 390,725.00 |
| Dec 31, 2019 | 390,988.00 |
| Sep 30, 2019 | 62,977.00 |
| Jun 30, 2019 | 502,479.00 |
| Mar 31, 2019 | 518,229.00 |
| Dec 31, 2018 | 526,473.00 |
| Sep 30, 2018 | 134,145.00 |
| Jun 30, 2018 | 468,039.00 |
| Mar 31, 2018 | 134,145.00 |
| Dec 31, 2017 | 529,018.00 |
| Jun 30, 2017 | 134,145.00 |
| Dec 31, 2016 | 478,096.00 |